Browse By: Country ι Category ι Publisher ι Tag

The World Pharmaceutical Markets Fact Book 2013

Pages » N/A
Published By » Espicom
Price » $1545
In stock
View Report Details
Description

The indispensable source of thousands of facts, figures and statistics for 67 pharmaceutical markets worldwide! The World Pharmaceutical Market Fact Book 2013 is the ideal companion in today’s challenging pharmaceutical market environment. The need to understand world pharmaceutical marketplaces, and be able to answer quickly those questions that arise daily, is essential. That is why this current and comprehensive source of key market statistics is an invaluable aid for every pharmaceutical industry executive. Proven and reliable Published by Espicom - experts in the healthcare field for over 30 years, the Fact Book brings together a range of often difficult to source infor... Click here for more details


Breast Cancer Drug Discoveries: What the Future Holds
In 2010, almost 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are required to increase survival and delay disease progression. Unique breast cancer market share, sales forecasts by launched and Phase III products to 2
Published Date: Aug 2011
Price: $3145
The Outlook for Pharmaceuticals in Brazil, Russia, India & China
These leading emerging economies represent a combined pharmaceutical market of US$132.2 billion. How have they emerged from the economic downturn? Where do commercial opportunities exist for pharmaceutical companies over the 2011-16 forecast period? Putting things in perspective...
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Central Asia
These reports analyse the issues These reports provide a detailed analysis of four of the most populous countries in the world and the massive potential of their pharmaceutical markets. The markets of Central Asia contrast well; China and India are two of the largest pharmaceutical markets with ver
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Central & Eastern Europe
The pharmaceutical market of Central & Eastern Europe is estimated at US$63.6 billion at retail prices in 2011; it is expected to reach US$104.2 billion by 2016. The market is expected to expand by a moderate CAGR in US dollar terms between 2011 and 2016, as the region’s economies reco
Published Date: Feb 2012
Price: $3630
E7: The Outlook for Pharmaceuticals to 2012
The E7 economies represent increasing opportunities for pharmaceutical companies constrained by maturing markets in the west. Huge potential in E7 markets The emerging E7 countries represent the best prospect for growth. The potential of these countries is huge: they have a combined
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Latin America
Strong pharmaceutical market growth opportunities and regulatory developments are making Latin America more attractive The region needs to increase drug access, despite intensifying cost-containment measures. Therefore, attractive opportunities for (bio)pharmaceutical producers exist in Latin A
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in the Middle East and North Africa
Macro-environmental conditions affected by political unrest In spite of recent political unrest, economic, social and demographic changes are making the pharmaceutical markets in the Middle East & North Africa (MENA) region more attractive. The Economist Intelligence Unit (EIU) forecasts th
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Northern Europe
The Northern European countries are projected to represent a combined pharmaceutical market value of over US$23 billion at retail prices by 2016. The seven Northern European pharmaceutical markets are diverse, from the stable well-developed markets of Scandinavia to the less well-funded
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in South East Asia
The eight pharmaceutical markets of South East Asia are developing at markedly different speeds and are characterised by contrasting macroeconomic factors. These markets are projected to have a combined pharmaceutical market value of US$69.1 billion at retail prices in 2016. Established&hel
Published Date: Feb 2012
Price: $3630
The Outlook for Pharmaceuticals in Western Europe
Market growth in the mature markets of Western Europe is assured over the coming years by the health needs of ageing populations, and will be driven by investment in innovative medicines, particularly in the hospital market. Growth, however, will be tempered somewhat by the effects of the glob
Published Date: Feb 2012
Price: $3630

 


 

Related News

The Manufacturing Supply Chains to be Restructured by 3D Printing Technology
The trend of 3D printing has evolved within a very short period of time. Back in the 1980s when it was built by Charles Hull, it was used as a tool for creating basic polymer objects. However, today this technology is proving its worth in various manufacturing sectors right from developing complex aircrafts and parts of racing cars, to prostheses and human organs. The business world today is recognizing the potential of 3D printing which ensures environmentally sustainable, efficient, and cos
Date: Nov 26

Banks Need Two Decades to Tackle ‘Toxic Culture’, says Cass Business School’s Report
“UK banks will be seen facing two decades to clear up the ‘toxic culture’ that was decades in making and has cost more than US$60 billion in compensation and fines”, Cass Business School and Think Tank New City Agenda concluded in a joint study report. According to the joint study report, from 2010 to 2014, banks were forced to compensate consumers by making provisions of at least US$42.51 billion for insurance products that were not sold properly. It has cost lenders
Date: Nov 26

Dutch Biotech Prosena gets Milestone Payments; BioMarin acquires it for US$840 Million
BioMarin Pharmaceuticals Inc. has agreed to pay US$840 million, which includes milestone payments, in accordance to buy Prosena, a Dutch bio-pharmaceutical company. The share prices of Prosena holding NV (RNA) rose above the offer that is made by BioMarin, after the announcement of the deal. With this deal, BioMarin focuses on the expansion of its portfolio of drugs to treat rare diseases as the acquisition will provide rights to various orphan drug candidates, mainly Drisapersen that is bein
Date: Nov 25

2,500 Construction Workers to be Tested in UAE
A project initiative had recently been launched in the UAE that is designed to test the skills of almost 2,500 workers in the construction sector before they gain entry into the UAE, as announced by the UAE Ministry of Labor. The Minister of Labor, Saqr Ghobash, said the new project comes as an attempt by the Ministry of Labor towards obtaining cooperation and partnership with concerned government bodies and companies from the private sector to obtain future labor market goals. This project a
Date: Nov 24

U.S. auto regulator Orders Expansion of Takata Air Bags Recalls
U.S. auto safety regulators have ordered Japanese safety equipment manufacturer Takata Corp and five automakers to expand recalls of cars which had Takata airbags in them. The companies ordered to expand recalls include Honda, Chrysler, BMW, Mazda and Ford.  Already, nearly 16 million cars from around the globe have been recalled over the issue of faulty Takata airbags in the past 6 years. Of these, nearly 11 million are from the U.S. alone. The pressure of expanding regional recalls of
Date: Nov 20

Telecom Italia Expresses Interest in Buying Stake in Metroweb
Italian telecommunications company Telecom Italia has expressed its desire to buy a controlling stake in Metroweb – Italian fiber optic provider. Telecom Italia is looking to increase its investments in faster networks and is being met with stiff competition from rival Vodafone who is also reportedly courting Metroweb.  Metroweb is owned by F2i, an infrastructure fund. F2i spokesperson informed the media that Metroweb had been getting investors for quite some time but the company h
Date: Nov 20

Baker Hughes to be taken over by Halliburton
Baker Hughes, a rival company of Halliburton’s, providing oilfield services will soon be bought by the latter for a deal worth US$ 34.6 billion. Such a step denotes the immediate impact that falling prices have on the energy industry. Over the past five months, worldwide oil prices have declined by almost 31%. Fall in oil prices are forcing the oil services companies to resort to cost cutting by either scaling back drilling or delaying the same. Thus, this means lesser work for Baker Hughe
Date: Nov 19

Asia Follows China in Push for Clean Energy
The Chinese economy is beginning to cool, but its requirement for energy is still on the rise. So is its capacity to generate this extra energy from various sources, including wind, solar, hydroelectric, coal and nuclear. Other Asian countries are quickly following suit due to skyrocketing energy needs where industrialization is overtaking the production of power from renewable sources. Experts calculate that more than US$250 billion will be spent per year in Asia to create more sources of
Date: Nov 19

RF Executives Plan to Capture the Mobile Market Via Merger
The planned amalgamation between Oregon-based TriQuint Semiconductor Inc., and Greensboro-based RF Micro Devices Inc., will allow this merger to grow into several areas of the industry, including the mobile markets and defense, said both the companies’ executives on Tuesday.  Both the company officials summarized plans about their unique position to win in the investor day presentation. However, the combined name of the company will be Qorvo.  Both TriQuint and RF manufactu
Date: Nov 19

Mexican Supplier Cooperation for BMW, Mercedes
Daimler is currently working with its rival automaker BMW to create a supplier chain for new factories in Mexico. This was announced on Monday by Klaus Zehender, the divisional board member for supplier quality and procurement at Mercedes-Benz, Daimler. The effort comes as a part of a larger one by Mercedes-Benz to expand its chain of local suppliers to their factories in China, South Africa, United States, and Mexico. In the first half of this year, Daimler and BMW announced their plans t
Date: Nov 18

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795